Literature DB >> 11741224

Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: application to nitric oxide synthase.

T Maurer1, H L Fung.   

Abstract

The goals of this study were (1) to investigate the performance of 2 classical methods of kinetic analysis when applied to data from enzyme systems in which mechanism-based inactivation and enzyme degradation are present, and (2) to develop and validate a nonlinear method of kinetic data analysis that may perform better under these situations. A composite equation was derived to link various parameters that govern the kinetics of mechanism-based inactivation, viz., enzyme activity, inhibitor-binding affinity (K(I)), inactivation rate (k(inact)), and enzyme degradation (k(deg)). The relative accuracy and precision of parameter estimation by the Dixon and Kitz-Wilson methods and a new nonlinear method were evaluated by computer simulation. The behavior of these methods of analysis were validated experimentally, using the nitric oxide synthase enzyme, both in purified form and as expressed in murine macrophage cell cultures. We showed that the Dixon method, as expected, could not provide accurate estimates of K(I) in the presence of either enzyme inactivation or instability. The Kitz-Wilson method could provide accurate estimates of these parameters; however, the precisions of these estimates were poorer than those obtained using the nonlinear method of analysis. We conclude that the nonlinear approach is superior to classical methods of data analysis for enzyme inhibitor kinetics, based on better efficiency, accuracy, and precision.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11741224      PMCID: PMC2751003          DOI: 10.1208/ps020108

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  23 in total

1.  1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo.

Authors:  E P Garvey; J A Oplinger; E S Furfine; R J Kiff; F Laszlo; B J Whittle; R G Knowles
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

Review 2.  Enzyme-activated/mechanism-based inhibitors.

Authors:  M G Palfreyman; P Bey; A Sjoerdsma
Journal:  Essays Biochem       Date:  1987       Impact factor: 8.000

Review 3.  Mechanism-based enzyme inactivators.

Authors:  R R Rando
Journal:  Pharmacol Rev       Date:  1984-06       Impact factor: 25.468

4.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

5.  "Suicide" inactivation of prostaglandin I2 synthase: characterization of mechanism-based inactivation with isolated enzyme and endothelial cells.

Authors:  M L Wade; N F Voelkel; F A Fitzpatrick
Journal:  Arch Biochem Biophys       Date:  1995-08-20       Impact factor: 4.013

6.  N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.

Authors:  D W Reif; S A McCreedy
Journal:  Arch Biochem Biophys       Date:  1995-06-20       Impact factor: 4.013

7.  NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase.

Authors:  N M Olken; M A Marletta
Journal:  Biochemistry       Date:  1993-09-21       Impact factor: 3.162

8.  Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline.

Authors:  E S Furfine; M F Harmon; J E Paith; R G Knowles; M Salter; R J Kiff; C Duffy; R Hazelwood; J A Oplinger; E P Garvey
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

9.  Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas.

Authors:  E P Garvey; J A Oplinger; G J Tanoury; P A Sherman; M Fowler; S Marshall; M F Harmon; J E Paith; E S Furfine
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

10.  Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity.

Authors:  P F Chen; A L Tsai; K K Wu
Journal:  Biochem Biophys Res Commun       Date:  1995-10-24       Impact factor: 3.575

View more
  12 in total

1.  Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease.

Authors:  Hailin Zheng; Mati Fridkin; Moussa B H Youdim
Journal:  Neurochem Res       Date:  2010-10-28       Impact factor: 3.996

2.  Selective acetylcholinesterase inhibitor activated by acetylcholinesterase releases an active chelator with neurorescuing and anti-amyloid activities.

Authors:  Hailin Zheng; Moussa B H Youdim; Mati Fridkin
Journal:  ACS Chem Neurosci       Date:  2010-10-04       Impact factor: 4.418

3.  Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.

Authors:  Joshua M Barnett; Gary W McCollum; Jessica A Fowler; James J-W Duan; Jesse D Kay; Rui-Qin Liu; David P Bingaman; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

4.  Mechanism-Based Inhibition of the Mycobacterium tuberculosis Branched-Chain Aminotransferase by d- and l-Cycloserine.

Authors:  Tathyana Mar Amorim Franco; Lorenza Favrot; Olivia Vergnolle; John S Blanchard
Journal:  ACS Chem Biol       Date:  2017-03-16       Impact factor: 5.100

5.  Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity.

Authors:  Stuart G Dashper; Yu Pan; Paul D Veith; Yu-Yen Chen; Elena C Y Toh; Sze Wei Liu; Keith J Cross; Eric C Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

6.  Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A.

Authors:  Lucy Lin; Margaret E Olson; Takashi Sugane; Lewis D Turner; Margarita A Tararina; Alexander L Nielsen; Elbek K Kurbanov; Sabine Pellett; Eric A Johnson; Seth M Cohen; Karen N Allen; Kim D Janda
Journal:  J Med Chem       Date:  2020-09-18       Impact factor: 7.446

7.  Inhibition of monoamine oxidase activity by cannabinoids.

Authors:  Zdenek Fisar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-18       Impact factor: 3.000

8.  Characterization and two-dimensional crystallization of membrane component AlkB of the medium-chain alkane hydroxylase system from Pseudomonas putida GPo1.

Authors:  Hernan Alonso; Anna Roujeinikova
Journal:  Appl Environ Microbiol       Date:  2012-08-31       Impact factor: 4.792

9.  Activity-Based Probes for 15-Lipoxygenase-1.

Authors:  Nikolaos Eleftheriadis; Stephanie A Thee; Martijn R H Zwinderman; Niek G J Leus; Frank J Dekker
Journal:  Angew Chem Int Ed Engl       Date:  2016-09-09       Impact factor: 15.336

10.  Novel selective and irreversible mosquito acetylcholinesterase inhibitors for controlling malaria and other mosquito-borne diseases.

Authors:  Dengfeng Dou; Jewn Giew Park; Sandeep Rana; Benjamin J Madden; Haobo Jiang; Yuan-Ping Pang
Journal:  Sci Rep       Date:  2013-01-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.